Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Go back to Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: AXSM) Delayed: 207.78 -6.5 (3.03%)
Previous Close $214.28    52 Week High $15.74 
Open $212.05    52 Week Low $5.37 
Day High $213.27    P/E N/A 
Day Low $206.92    EPS $0.00 
Volume 869,297